SBM — Sirona Biochem Cashflow Statement
0.000.00%
Last trade - 00:00- CA$15.82m
- CA$19.10m
- CA$0.03m
Annual cashflow statement for Sirona Biochem, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.55 | -4.13 | -2.31 | -3.56 | -2.54 |
| Depreciation | |||||
| Non-Cash Items | 1.08 | 1.62 | 0.337 | 1.67 | 0.223 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.086 | 0.393 | -0.198 | -0.295 | 0.553 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.56 | -2.11 | -2.16 | -2.18 | -1.76 |
| Capital Expenditures | — | -0.047 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.047 | 0 | — | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.96 | -0.046 | 1.45 | 2.04 | 1.75 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.4 | -2.2 | -0.758 | -0.356 | 0.15 |